Tag: PhaseBio Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals (PHAS) Posts Quarterly Earnings Results, Beats Expectations By $0.14 ...

Added to Collection on: 2019-05-25 21:52:30

Tags for this article:

Price?earnings ratio
Life Sciences
Biotechnology
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Pharmaceuticals (PHAS) Issues Quarterly Earnings Results

Added to Collection on: 2019-05-25 20:56:15

Tags for this article:

Occupations
Securities research
Economy
Price?earnings ratio
Industry economics)
Service industries
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Pharmaceuticals (PHAS) PT Set at $27.00 by Citigroup

Added to Collection on: 2019-05-27 18:07:30

Tags for this article:

Money
Finance
Hedge fund
Economy
Citigroup
Financial analyst
Securities research
Occupations
Price–earnings ratio
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Citigroup Analysts Give PhaseBio Pharmaceuticals (PHAS) a $27.00 Price Target

Added to Collection on: 2019-05-27 18:07:30

Tags for this article:

Money
Finance
Economy
Citigroup
Financial analyst
Securities research
Occupations
Price–earnings ratio
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Pharmaceuticals (PHAS) Given a $27.00 Price Target at Citigroup

Added to Collection on: 2019-05-27 11:45:00

Tags for this article:

Money
Finance
Economy
Citigroup
Financial analyst
Securities research
Occupations
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Pharmaceuticals (NASDAQ:PHAS) Issues Earnings Results, Beats Estimates By $0.14 ...

Added to Collection on: 2019-06-01 21:51:32

Tags for this article:

NASDAQ COMPOSITE INDEX
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Pharmaceuticals (PHAS) Releases Quarterly Earnings Results

Added to Collection on: 2019-06-02 16:03:45

Tags for this article:

Price–earnings ratio
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Pharmaceuticals (NASDAQ:PHAS) Posts Quarterly Earnings Results, Beats Estimates ...

Added to Collection on: 2019-06-02 14:04:01

Tags for this article:

New York City
Economy of New York City
Subprime mortgage crisis
Citigroup
Midtown Manhattan
Companies
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Pharmaceuticals (NASDAQ:PHAS) Price Target Increased to $19.00 by Analysts at ...

Added to Collection on: 2021-03-16 14:15:00

Tags for this article:

Finance
Financial markets
Money
Stock market
Price?earnings ratio
NASDAQ
BlackRock
Stock
Short
PhaseBio Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
PhaseBio Reversal Agent Continues to Show Promise in Phase III | BioSpace

Added to Collection on: 2021-11-15 16:50:01

Tags for this article:

Cyclopropanes
Alcohols
Ticagrelor
Antiplatelet drug
Bentracimab
P2Y12
Clinical medicine
Chemical substances
Chemistry
Adenosine diphosphate receptor inhibitor
Jonathan Mow
PhaseBio Pharmaceuticals
Brilinta

Click the tags to see associated articles and topics

View Article Details